Numab Therapeutics AG
Biotechnology · Horgen, Zurich
Numab Therapeutics AG is a Swiss biotechnology company based in Horgen, Canton of Zurich, listed in the Swiss commercial register since 2016 (UID CHE-199.155.103).
Board members & signatories
- Carlo Incerti — Präsident des Verwaltungsrates
- Barbara Angehrn — Mitglied des Verwaltungsrates
- Oliver Middendorp — Mitglied des Verwaltungsrates
Registered purpose
Die Gesellschaft bezweckt die Entwicklung und Produktion sowie den Handel mit biologischen oder pharmazeutischen Produkten mit therapeutischem, diagnostischem oder forschungsdienlichem Potenzial. Zudem kann die Gesellschaft Beratungsdienstleistungen in den genannten Geschäftsfeldern erbringen. Die Gesellschaft kann Immaterialgüterrechte und Lizenzen jedwelcher Art erwerben, halten, verwerten oder …
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of September 2026
What Numab Therapeutics does
OFFERING
Numab Therapeutics AG develops multispecific antibody-based immunotherapies targeting inflammation and cancer. Their proprietary platforms, λ-Cap™ and MATCH™, facilitate a reproducible therapeutic design process, enabling the creation of differentiated therapeutics. The company is advancing a pipeline of next-generation immunology and immuno-oncology drugs, including their lead candidate NM26, aimed at treating atopic dermatitis.
Unlock the full analysis →Similar companies
- Neurimmune Holding AG — Biotechnology · Schlieren
- Mabylon AG — Biotechnology · Schlieren
- NBE-Therapeutics AG — Biotechnology · Basel
- Neurimmune Subone AG — Biotechnology · Schlieren
- ADC Therapeutics AG — Biotechnology · Epalinges
- Tubulis Sàrl — Biotechnology · Epalinges
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime